Health in Your Hands
A proposal for building the personal health intelligence layer that 1.8 billion people in the African diaspora do not yet have — and that Flossie Belle Johnson, who lived to 104, built by hand.
Project Flossie
My grandmother, Flossie Belle Johnson, lived to 104. She did not have a physician dashboard, a wearable sensor, or a cloud-based health record. What she had was a system — a daily practice of observation, adjustment, and accountability that she maintained for over a century. She knew her body. She tracked what she ate, how she moved, how she slept, and what changed.
Project Flossie is the digital architecture of that practice. Named in her honor, it is a personal health command center that integrates real-time biometric data, clinical records, supplement and medication management, adaptive coaching, and longitudinal pattern recognition — all governed by the individual, not the institution.
The technology stack exists today. The intelligence layer does not. That is what we are building.
I Am the Dataset
I am not presenting a product proposal. I am presenting myself. I am a 78-year-old African American man — a stolen returning son — running a six-layer personal health intelligence system on my own body. My target is my grandmother's number: 104.
No letters after my name. No institutional pedigree. A GED, 78 years of lived data, and currently enrolled in the Ganjier Certification Program — the Cannabis Sommelier Certification — the only credential that matters for what Layer 06 requires.
I waive my own HIPAA protections voluntarily, removing every institutional barrier between this architecture and anyone who wants to examine it. No review boards. No compliance firewalls. The prototype is sitting across the table from you.
I'm your Huckleberry.
78 years of uninterrupted data. No IRB required.
Six Layers, One Address Space
Flossie operates on the principle that health data — like all intelligence — must share a single address space to be useful. Fragmented systems produce fragmented care. The architecture integrates six layers:
What exists today: Epic MyChart holds clinical records in a physician-facing silo. Apple Health collects biometrics in a consumer-facing dashboard that no clinician reads. Pharmacy apps track refills but not effects. Cannabis products are sold by THC percentage with no tracking of outcomes. No system connects these data streams into a unified intelligence layer governed by the individual. That is what Flossie builds — and it does not yet exist for the 1.8 billion people in the African diaspora.
Biometric Capture
Two sensing systems — one on the wrist, one implanted in the chest. The Apple Watch Ultra 3 streams heart rate, blood oxygen, sleep architecture, and activity 24/7 into a unified data lake. Underneath the collarbone, an Inspire neurostimulator — an FDA-approved implanted computer — monitors every breath during sleep and sends electrical pulses to the hypoglossal nerve to keep the airway open. In the STAR trial published in the New England Journal of Medicine, this device achieved a 78% reduction in apnea events at 36 months. The prototype doesn't just wear sensors. He has one surgically installed inside his body, reporting to clinical care in real time.
Clinical Integration
MyChart / UCLA Health as the institutional interface. Lab results, provider notes, appointment scheduling, medication lists — pulled into the same system that holds the biometric stream.
Adaptive Intelligence
Claude API (Anthropic) as the daily coaching engine. Not a chatbot. A reasoning layer that reads the biometric data, cross-references clinical records, and produces adaptive daily guidance — exercise, nutrition, supplement timing, rest protocols — calibrated to what actually happened yesterday, not a generic template. Daily terpene journal entries from Layer 06 feed into Claude for cross-referencing against sleep architecture data from Layer 01 and lab results from Layer 02 — producing a unified daily protocol. The AI reads the whole body, not one chart at a time.
Physical Interface
A connected strength and movement system (Tonal 2 or equivalent) that receives coaching instructions from the intelligence layer. The body is the output device. The AI is the coach. The human is the principal.
Practice Management
Supplement tracking, medication scheduling, pharmacy integration (CVS/Walgreens app layer), refill automation, and the daily "pill box" ritual — digitized but rooted in the physical practice Flossie maintained for a century.
ECS Activation
The endocannabinoid system is the body's master regulator — maintaining homeostasis across the brain, endocrine system, immune system, sleep, pain, inflammation, and mood. It evolved in vertebrate animals over 600 million years ago — 575 million years before the cannabis plant appeared. The system is named after the plant, not the other way around.
Layer 06 activates the ECS through intentional consumption of cannabinoids (CBD, THC, CBG) and terpenes from all botanical sources — not just cannabis. Lavender, citrus, black pepper, moringa, rosemary, and dozens of other plants produce the same terpenes that activate cannabinoid receptors. Moringa — the "Miracle Tree," native to the African continent, containing beta-caryophyllene and linalool — is a textbook non-cannabis ECS activator that has been in African traditional medicine for millennia. The Terpene Journal is the practice tool that tracks these inputs and feeds the data to Layer 03 (Claude API) for adaptive coaching.
For a prototype targeting 104, the master regulator is not optional. Leaving it unactivated would be like running a recording studio with no mixing board.
The Terpene Journal tracks ECS activation using ISO-accredited chemometric profiling across 39 terpene analytes, mapped to a six-spoke entourage effects framework (Relaxation, Focus, Energy, Inspiration, Calm, Comfort) derived from the pharmacological research of Russo and Lewis. The same terpene panel applies to every botanical source — cannabis, moringa, lavender, citrus, black pepper, rosemary. The journal builds a personal pharmacological profile over time: which terpene families produce which effects for this specific body.
The prototype's daily botanical inputs — Room 403, ADIS26.
Every bottle is a terpene delivery system. Not just cannabis. All botanical sources.
The Evidence Builds the Platform
Project Flossie is not a product proposal. It is a gated evidence pipeline — each gate produces the data and documentation that unlocks the next. The personal prototype is already operational. The path from one body to a diaspora health platform follows three funding gates, each mapped to a specific capital source.
$100,000–$200,000
The system works on one person. Apple Watch Ultra 3 biometric capture, clinical integration via MyChart/UCLA Health, Claude API adaptive coaching layer, connected movement interface, and daily practice management — all operational, documented, and producing longitudinal health data. The African-based engineering team that builds the integration layer is contracted in Gate 1 itself. The diaspora capital recycling begins at the proof-of-concept stage, not as an afterthought at scale.
Funding source: Gates Grand Challenges Explorations — Phase 1 individual grants begin at $100K, collaborative grants at $200K, 18-month term.
$500,000–$1,000,000
The system works across 50–100 people in a diaspora health population. Platform build-out, cohort recruitment through community health access points, outcomes measurement against standard-of-care baselines, and peer-reviewed documentation of results. The intelligence layer runs on Anthropic's Claude API — Anthropic is the inaugural AI partner of NextLadder Ventures, the $1 billion initiative launched by Gates, Ballmer, Koch, Cook, and Overdeck. NextLadder's mandate is personalized solutions for individuals navigating health crises. Flossie is that mandate in production.
Funding source: NextLadder Ventures — AI infrastructure already embedded, health crises explicitly in scope, mix of grants and equity financing.
$2,000,000–$5,000,000
Scaling the architecture to African and diaspora communities at population level. Engineering team expansion — contracted exclusively to African-based development agencies. Integration of the wellness literacy layer as a community practitioner tool. Hardware-agnostic deployment across both Apple and Windows health ecosystems, proving the platform is a protocol, not a product tied to one manufacturer. The budget proves the thesis: diaspora capital, built by diaspora engineers, serving diaspora health.
Funding source: Skoll Foundation, Wellcome Trust, or aligned Series A investors. Gate 3 activates when Gate 1 evidence is six months mature and Gate 2 cohort is launching.
April 28, 2026
Gates Grand Challenges currently has an open call — including an AI-to-accelerate track — closing April 28, 2026. That is 34 days from the opening of this symposium.
The conversation in this room this week is not abstract. It maps directly to an active submission window. Gate 1 is not a five-year plan. It is a 34-day runway to application, an 18-month term to evidence, and a pathway to the next $5 million in diaspora health infrastructure.
Why This Room, Why Now
I am a stolen returning son. I bring back to my native land the skills I developed in America — AI architecture, health literacy systems, market intelligence. I do not come back empty-handed.
The African Diaspora Investment Symposium is where $95 billion in annual diaspora remittances is actively converting into structured investment. The Health in Your Hands workshop — co-facilitated by Josh Ghaim and Michael Moscherosch, with Priscilla Asante, in partnership with Opella — is designing an innovation challenge for exactly the category Project Flossie occupies.
Nine African nations have legalized commercial cannabis. Morocco grew its licensed cultivator base from 430 to 5,000 in two years. PAPSS, the pan-African payment rail, is operational across 19 countries. The Smart Africa coalition is architecting digital health policy for 54 nations. The infrastructure is live. The personal health intelligence layer is missing.
My daughter, Heather C. McGhee, wrote The Sum of Us — the thesis that when we design systems that include everyone, everyone gains more. She calls it the Solidarity Dividend. Project Flossie is the Solidarity Dividend applied to health: a system designed in one family, built to scale across a diaspora.
Flossie Belle Johnson built the practice. We are building the platform.The Conversation
If what you have read here warrants a conversation, I am in the room. The prototype is available.
Earl J. McGhee Jr.
Managing Evangelist, McGhee Consulting Group L.L.C.
earl@macearl.com
(872) 314-3526